SYNERCID
Live / Registered — Registered and renewed (as of 07 Jan 2021)
What this means for you
Registered since 17 Oct 2000. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Oct 2020).
Record
- Serial number
- 75491359
- Registration number
- 2396275
- Mark type
- Design + words
- Filed
- 27 May 1998
- Published for opposition
- 13 Jul 1999
- Registered
- 17 Oct 2000
- Next maintenance due
- 17 Oct 2020
- Attorney of record
- Heather A. McDonald
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INFECTIOUS DISEASES
Owner
- KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, LLC, New York, NY, US
- KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC., Cary, NC, US
- AVENTIS PHARMA SA, ANTONY, 92160, FR
- AVENTIS PHARMA SA, ANTONY, 92160, FR
- Rhone-Poulenc Rorer S.A., 92160 Antony, FR
- Rhone-Poulenc Rorer S.A., 92160 Antony, FR
Prior registrations
Prosecution history
- 28 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 28 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Mar 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Mar 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Mar 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Mar 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Jan 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 07 Jan 2021 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 07 Jan 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 07 Jan 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Oct 2020 — TEAS SECTION 8 & 9 RECEIVED
- 18 May 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED